Kabiven (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Kabiven is used in the clinical setting to address protein and nitrogen needs via the parenteral nutrition pathway.

• Inability to receive enteral feeding: supplies a complete amino acid profile intravenously to meet daily protein requirements.
• Post‑operative or trauma care: supports nitrogen balance and tissue repair during the recovery phase.
• Critical illness or severe malnutrition: maintains metabolic functions and prevents catabolism in patients with high metabolic demand.

• Kabiven delivers a balanced mixture of essential and non‑essential amino acids directly into the bloodstream. These amino acids are taken up by cells and incorporated into protein synthesis pathways, restoring nitrogen balance, supporting tissue repair, and sustaining metabolic processes in patients who cannot obtain nutrition through the gastrointestinal tract.

Kabiven may be associated with infusion‑related reactions and metabolic changes.

Common Side Effects

• Infusion site erythema or pain
• Mild hyperglycemia
• Electrolyte disturbances (e.g., mild hypernatremia)
• Nausea or vomiting
• Headache
• Low‑grade fever

Serious or Rare Side Effects

• Anaphylactic or severe hypersensitivity reaction
• Severe hypernatremia or metabolic acidosis
• Acute renal dysfunction
• Hepatic enzyme elevation
• Sepsis related to catheter use
• Thrombophlebitis at the infusion site

When using Kabiven, clinicians should consider several safety measures.

• Renal function assessment: evaluate baseline creatinine and adjust infusion if impaired.
• Hepatic function monitoring: watch liver enzymes and bilirubin during therapy.
• Electrolyte and glucose surveillance: check serum levels regularly to detect imbalances.
• Compatibility check: ensure solution is mixed only with compatible IV fluids.
• Hypersensitivity screening: avoid in patients with known allergy to any amino acid component.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kabiven can interact with other agents that affect electrolyte or metabolic balance.

Major Interactions (Avoid)

• Concurrent high‑dose potassium chloride: risk of severe hyperkalemia.
• Co‑administration with other amino acid solutions: may cause amino acid overload and metabolic disturbances.
• Use with nephrotoxic drugs (e.g., aminoglycosides) in patients with compromised renal function.

Moderate Interactions (Monitor Closely)

• Concurrent insulin therapy: may potentiate hypoglycemia.
• Diuretics that alter electrolyte status: monitor sodium and potassium levels.
• Steroids or catecholamines: may increase protein catabolism, requiring dosage adjustment.